Table 5.
Treatment Trials for Celiac Disease
| Therapy | NCT ID | Sponsor | Status* |
|---|---|---|---|
| ALV003 | 01255696 | Alvine | Complete |
| AN-PEP | 00810654 | VU Med Ctr | Complete |
| AT1001 | 01396213 | Alba | Complete |
| ALV003 | 00959114 | Alvine | Complete |
| AT1001 | 00620451 | Alba | Complete |
| AT1001 | 00492960 | Alba | Complete |
| AT1001 | 00889473 | Alba | Complete |
| AT1001 | 00386165 | Alba | Complete |
| ALV003 | 00859391 | Alvine | Complete |
| AT1001 | 00362856 | Alba | Complete |
| ALV003 | 00626184 | Alvine | Complete |
| NexVax | 008879749 | Nexpep Pty | Complete |
ALV003 and AN-PEP, prolylendopeptidases; AT1001, larazotide acetate; NexVax, vaccine for immune tolerance induction.
*
Listed as completed on clinicaltrials.gov.